Yiheng Capital Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-469,981	Closed	-$6.82M	–	28
2025 Q3	$6.82M	Hold	469,981	–	–	2.26%	16
2025 Q2	$6.58M	Hold	469,981	–	–	2.38%	16
2025 Q1	$6.39M	Sell	469,981 -230,117	-33%	-$4.41M	2.25%	15
2024 Q4	$14.3M	Buy	700,098 +100,000	+17%	+$2.56M	3.16%	15
2024 Q3	$17.5M	Sell	600,098 -550,586	-48%	-$13.6M	3.23%	13
2024 Q2	$26.7M	Hold	1,150,684	–	–	3.77%	14
2024 Q1	$23.6M	Hold	1,150,684	–	–	3.39%	13
2023 Q4	$24.7M	Hold	1,150,684	–	–	3.06%	13
2023 Q3	$23.7M	Hold	1,150,684	–	–	2.14%	16
2023 Q2	$34M	Buy	1,150,684 +136,000	+13%	+$3.82M	2.95%	15
2023 Q1	$23.4M	Hold	1,014,684	–	–	1.82%	19
2022 Q4	$28.2M	Hold	1,014,684	–	–	2.19%	16
2022 Q3	$31.1M	Hold	1,014,684	–	–	2.93%	14
2022 Q2	$29.9M	Hold	1,014,684	–	–	2.14%	19
2022 Q1	$32.6M	Buy	1,014,684 +679,500	+203%	+$23.4M	2.09%	20
2021 Q4	$14.9M	Buy	+335,184	New	+$15.9M	0.76%	23